FTL004 is an anti-CD38 monoclonal antibody. FTL004 exhibits enhanced Proapoptotic activity and displays stronger ADCC against CD38+ malignant cells. FTL004 can be used for the research of multiple myeloma and non-Hodgkin lymphoma[1].
Target:
Apoptosis,CD38
Application Notes:
MCE Product type: Inhibitory Antibodies
* VAT and and shipping costs not included. Errors and price changes excepted
